Clinical Trial

Comparison of 3Mixtatin Pulpotomy and Metapex Pulpectomy in Primary Molars With Irreversible Pulpitis

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The present study aims to evaluate the clinical and radiographic success of pulpotomy using 3Mixtatin versus pulpectomy using Metapex in primary molars with irreversible pulpitis in children aged 4 to 9 years.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-06.
Trial Details
NCT Number NCT06925490
Lead Sponsor Cairo University
Conditions Irreversible Pulpitis, Primary Teeth, Pulp Disease, Dental
Enrollment 50 participants
Start Date 2025-06
Primary Completion 2026-09 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-04-27